IE35186L - Amines - Google Patents

Abstract

1334430 Aralkylamines and derivatives F HOFFMANN-LA ROCHE & CO AG 5 May 1971 [6 May 1970] 13220/71 Heading C2C Novel compounds of formula wherein one of the symbols R 1 and R 2 represents a formyl group and the other symbol represents a hydroxy group (the symbols R 1 and R 2 being in the ortho- or para-position to each other), the symbols R 3 and R 4 each represents a hydrogen atom or a lower alkyl group, the symbol R 5 represents a hydrogen atom or a carboxyl or lower alkoxycarbonyl group and the symbol R 6 represents a hydrogen atom or a lower alkanoyl or aroyl group, their optical antipodes and pharmaceutically acceptable salts thereof are prepared by formylation of a compound of formula wherein one of the symbols R 7 and R 8 represents a hydrogen atom and the other symbol represents a hydroxy group or a lower alkoxy group (the symbols R 7 and R 8 being in the ortho- or para-position to each other), or an optical antipode or a salt thereof and converting any lower alkoxy group denoted by R 7 or R 8 in the formylation product into a hydroxy group and, if desired and in any desired sequence, converting a compound of Formula I obtained in which the symbol R 5 represents a lower alkoxycarbonyl group into a compound of Formula I in which the symbol R 5 represents a carboxyl group, esterifying a compound of Formula I in which the symbol R 5 represents a carboxyl group, converting a compound of Formula I in which the symbol R 6 represents a lower alkanoyl or aroyl group into a compound of Formula I in which the symbol R 6 represents a hydrogen atom if desired, optionally with salt formation and/or resolution. Pharmaceutical compositions in conventional forms for enteral or parenteral administration and having hypotensive and appetite inhibiting action comprise an above novel compound or salt and a carrier therefor. [GB1334430A]